TLPH
Talphera Inc.
NASDAQ: TLPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.91
+12.40% today
Updated 2026-04-30
Market cap
$38.27M
P/E ratio
—
P/S ratio
1,366.72x
EPS (TTM)
$-0.34
Dividend yield
—
52W range
$0 – $2
Volume
0.2M
Talphera Inc. (TLPH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-48,157.00%
ROE
-114.70%
ROA
-35.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | — | $-9.63M | — | — | — |
| 2008 | — | $-20.66M | — | — | — |
| 2009 | — | $-20.12M | — | — | — |
| 2010 | — | $-14.34M | — | — | — |
| 2011 | $1.07M | $-20.10M | 100.00% | -1,805.22% | -1,875.09% |
| 2012 | $2.39M | $-33.36M | 74.73% | -1,241.14% | -1,393.61% |
| 2013 | $29.50M | $-23.43M | 10.88% | -22.60% | -79.40% |
| 2014 | $5.22M | $-33.35M | -370.00% | -721.66% | -639.31% |
| 2015 | $19.26M | $-24.40M | -25.93% | -99.66% | -126.66% |
| 2016 | $17.36M | $-43.16M | 29.05% | -184.12% | -248.64% |
| 2017 | $8.00M | $-51.51M | -33.32% | -483.83% | -644.25% |
| 2018 | $2.15M | $-47.15M | -84.84% | -1,660.95% | -2,191.96% |
| 2019 | $2.29M | $-53.24M | -197.34% | -2,368.06% | -2,325.91% |
| 2020 | $5.42M | $-40.38M | -11.37% | -756.33% | -745.55% |
| 2021 | $378000.00 | $-35.10M | -695.24% | -4,792.59% | -9,285.45% |
| 2022 | $1.77M | $42.52M | -93.00% | -1,149.18% | 2,400.62% |
| 2023 | $651000.00 | $-18.40M | -751.92% | -2,594.32% | -2,825.96% |
| 2024 | $0.00 | $-13.00M | — | — | — |
| 2025 | $28000.00 | $-14.29M | 100.00% | -48,157.14% | -51,035.71% |